NCT02154919已完成不适用
Conservative Pharmacotherapy Versus Staged Percutaneous Coronary Intervention on Non-culprit Vessels for ST-Segment Elevation Myocardial Infarction Patients With Multivessel Disease
Beijing Shijitan Hospital, Capital Medical University1 个研究点 分布在 1 个国家目标入组 306 人开始时间: 2011年4月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 306
- 试验地点
- 1
- 主要终点
- Major Adverse Cardiovascular Events
研究概览
简要总结
To compare the different effect of conservative pharmacotherapy and Staged Percutaneous Coronary Intervention (SPCI) on significant non-culprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) at presentation remains controversial
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •age 18 to 75 with continuous ischemic chest pain for ≥ 30 minutes and ST-segment of electrocardiographic leads between V2 and V3 elevated ≥ 0.2 mV (or ≥ 0.1 mV in ≥ 2 other continuous electrocardiographic leads), cardiac troponin I (cTn I) elevation of > 0.05 ng/ml, coronary arteriography within 12 hours after the onset of symptoms indicating lesion in culprit vessel with thrombolysis in myocardial infarction (TIMI) flow grade 0 to 1, merely underwent PPCI. Additionally, coronary arteriography corroborates lesions in non-culprit vessel (Besides the culprit vessel, there are ≥ 70% stenoses in one or more coronary vessels in which diameters were ≥ 2 mm).
排除标准
- •left main coronary artery disease, cardiogenic shock, complete left bundle branch block (CLBBB) PPCI treated culprit and non-culprit vessels, PPCI failure patients with postsurgical haemodynamic instability or spontaneous ischemia, ≥ 70% stenoses of vessels remained during the hospitalization after staged PCI, history of PCI or Coronary Artery Bypass Grafting (CABG), history of chronic cardiac failure, bleeding diathesis, prior administration of thrombolytic therapy, known thrombopenia or leucopenia, sever liver and kidney dysfunction, active infection, immune system and connective tissue diseases, known contraindications to aspirin or heparin, life expectancy < 1 year, had major procedure within 3 months, uncontrolled hypertension, ischemic stroke within 30 days, hemorrhagic stroke, intracranial diseases including and arteriovenous malformation, extensive traumatic cerebral infarction within 6 weeks, oral anticoagulant therapy, severe myocardial infarction related complications and perioperative death
结局指标
主要结局
Major Adverse Cardiovascular Events
时间窗: 360days
次要结局
未报告次要终点
研究者
Peng Jian Jun
Beijing Shijitan Hospital, Capital Medical University , Beijing, China
Beijing Shijitan Hospital, Capital Medical University
研究点 (1)
Loading locations...
相似试验
终止
3 期
Assessment of Revascularization Versus Conservative Treatment in Heart Transplant Patients for a Clinical Event ReductionHeart-lung Transplant RejectionNCT01795729Assistance Publique - Hôpitaux de Paris6
Unknown
不适用
Fast Radial Pharmaco-invasive Strategy In ST Elevation Myocardial Infarction TrialST-segment Elevation Myocardial Infarction (STEMI)NCT04300582University of Sao Paulo General Hospital120
已完成
不适用
Percutaneous coronary intervention versus conservative treatment in patients with stable angina pectoris (EUREGIO AP study): Can magnetic resonance perfusion imaging improve the triage of patients with stable angina?10011082AtherosclerosisNL-OMON34978Cardiologie400
Unknown
不适用
Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium StentCoronary Artery DiseaseNCT02014818Kobe University104
招募中
4 期
Pharmacodynamic Outcomes in CCS Patients Treated With an Individualized Treatment StrategyPlatelet ReactivityCoronary Artery DiseaseNCT05773989St. Antonius Hospital88